References
- Drake-Lee A, Lowe D, Swanston A, Grace A. Clinical profile and recurrence of nasal polyps. J Laryngol Otol 1984; 98: 783–93.
- Tos M, Mogensen C. Pathogenesis of nasal polyps. Rhinology 1977; 15: 87–95.
- Cauna N, Hindover K, Manzethi G, Swanson E. Fine structure of nasal polyps. Ann Otol Rhinol Laryngol 1972; 81: 41–58.
- Watanabe K, Saito Y, Watanabe I, Mizuhira V. Char-acteristics of capillary permeability in nasal mucosa. Ann Otol 1980; 89: 377–82.
- Petruson B, Hansson H-A, Petruson K. Insulinlike growth factor I immunoreactivity in nasal polyps. Arch Otolaryngol Head Neck Surg 1988; 114: 1272–5.
- Ohno I, Lea RG, Flanders KC, et al. Eosinophils in chronically inflamed human upper airway tissues ex-press transforming growth factor in gene (TGFB1). J Clin Invest 1992; 89: 1662–8.
- Pyykkö I, Ishizaki H, Van Setten G. Expression of basic fibroblast growth factor in nasal polyps. Otolar-yngol Head Neck Surg 1998; 119: 121.
- Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4–25.
- Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biol 1991; 47: 219–23.
- Ito A, Hirota S, Mizuno H, et al. Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of oedema in chronic inflammation. Pathol Int 1995; 45: 715–20.
- Holopainen E, Mäkinen J, Paavolainen, Palva T, Salo OP. Nasal polyposis. Relationships to allergy and acetylsalicylic acid intolerance. Acta Otolaryngol (Stockh) 1979; 87: 330–334.
- Roberts G, Palade G. Increased microvascular perme-ability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Science 1995; 108: 2369–79.
- Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 1998; 273: 8413–8.
- Sasaki Y. Distribution of the degranulated and non-de-granulated mast cells in nasal polyp. Acta Otolaryngol (Stockh) 1986; Suppl. 430: 34–38.
- Boesiger J, Tsai M, Maurer M, et al. Mast cells can secrete vascular permeability factor/vascular en-dothelial cell growth factor and exhibit enhanced re-lease after immunoglobulin E-dependent upregulation of Fcr receptor I expression. J Exp Med 1998; 188: 1135 —45.
- Griitzkau A, Krfiger-Krasagakes S, Baumeister H, et al. Synthesis, storage, and release of vascular endothe-lial growth factor/vascular permeability factor (VEGF/ VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 1998; 9: 875–84.
- Yamada T, Sawatsubashi M, Yakushiji H, et al. Local-ization of vascular endothelial growth factor in syn-ovial membrane mast cells: examination with "multi-labeling subtraction immunostaining". Vir-chows Arch 1998; 433: 567–70.